Early Free Light‐Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA‐Directed CAR‐T Cells
ABSTRACT Background Relapsed/refractory multiple myeloma (RRMM) remains difficult to treat despite advances in therapy. B‐cell maturation antigen (BCMA)‐directed chimeric antigen receptor T‐cell (CAR‐T) therapies, such as idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel), ha...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2025-10-01
|
| Serier: | eJHaem |
| Fag: | |
| Online adgang: | https://doi.org/10.1002/jha2.70139 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
